Concord Wealth Partners’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Concord Wealth Partners’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-242	Closed	-$7K	–	1074
2021 Q2	$7K	Buy	+242	New	+$4.76K	﹤0.01%	696

Concord Wealth Partners's TBIO Position: Q3 2021 in Review

Concord Wealth Partners sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 242 shares — an estimated $7K sold.

Concord Wealth Partners first reported a position in TBIO in Q2 2021 and held it in 1 quarter. The position peaked at $7K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Concord Wealth Partners reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Concord Wealth Partners sold 242 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $7K.
Concord Wealth Partners first reported a position in Translate Bio, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
Concord Wealth Partners's Translate Bio, Inc. Common Stock position peaked at $7K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Concord Wealth Partners's 13F filing for Q3 2021, filed 9 Nov 2021.